Literature DB >> 27316712

Erratum to: Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer.

Liang Feng^1,2, Hang-Ping Yao^1,2, Sharad Sharma², Yong-Qing Zhou³, Jianwei Zhou⁴, Ruiwen Zhang⁵, Ming-Hai Wang^6,7.

Abstract

Entities: Chemical Disease Gene

Year: 2016 PMID： 27316712 PMCID： PMC4912733 DOI： 10.1186/s13046-016-0364-5

Source DB: PubMed Journal: J Exp Clin Cancer Res ISSN： 0392-9078

× No keyword cloud information.

Erratum

Unfortunately, the original version of this article [1] contained an error. The name of one of the authors, Sharad Sharma, was not included in the author list. The correct author list and the new “Authors’ contributions” section have been correctly included in full in this erratum and updated in the original article.

1 in total

1. Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer.

Authors: Liang Feng; Hang-Ping Yao; Yong-Qing Zhou; Jianwei Zhou; Ruiwen Zhang; Ming-Hai Wang
Journal: J Exp Clin Cancer Res Date: 2016-04-22

1 in total